Page last updated: 2024-09-03

24,25-epoxycholesterol and mevastatin

24,25-epoxycholesterol has been researched along with mevastatin in 1 studies

Compound Research Comparison

Studies
(24,25-epoxycholesterol)
Trials
(24,25-epoxycholesterol)
Recent Studies (post-2010)
(24,25-epoxycholesterol)
Studies
(mevastatin)
Trials
(mevastatin)
Recent Studies (post-2010) (mevastatin)
65018495367

Protein Interaction Comparison

ProteinTaxonomy24,25-epoxycholesterol (IC50)mevastatin (IC50)
3-hydroxy-3-methylglutaryl-coenzyme A reductaseHomo sapiens (human)0.0484
Insulin receptor Rattus norvegicus (Norway rat)0.119
Prostaglandin G/H synthase 2Homo sapiens (human)0.119
3-hydroxy-3-methylglutaryl-coenzyme A reductase Rattus norvegicus (Norway rat)0.134

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, AJ; Quinn, CM; Wong, J1

Other Studies

1 other study(ies) available for 24,25-epoxycholesterol and mevastatin

ArticleYear
Statins inhibit synthesis of an oxysterol ligand for the liver x receptor in human macrophages with consequences for cholesterol flux.
    Arteriosclerosis, thrombosis, and vascular biology, 2004, Volume: 24, Issue:12

    Topics: ATP Binding Cassette Transporter 1; ATP Binding Cassette Transporter, Subfamily G, Member 1; ATP-Binding Cassette Transporters; Cell Differentiation; Cell Line; Cholesterol; DNA-Binding Proteins; Gene Expression Regulation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ligands; Liver X Receptors; Lovastatin; Macrophages; Monocytes; Orphan Nuclear Receptors; Receptors, Cytoplasmic and Nuclear; Tetradecanoylphorbol Acetate

2004